Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Holly Y. Young"'
Autor:
Thomas C Schulz, Holly Y Young, Alan D Agulnick, M Josephine Babin, Emmanuel E Baetge, Anne G Bang, Anindita Bhoumik, Igor Cepa, Rosemary M Cesario, Carl Haakmeester, Kuniko Kadoya, Jonathan R Kelly, Justin Kerr, Laura A Martinson, Amanda B McLean, Mark A Moorman, Janice K Payne, Mike Richardson, Kelly G Ross, Eric S Sherrer, Xuehong Song, Alistair Z Wilson, Eugene P Brandon, Chad E Green, Evert J Kroon, Olivia G Kelly, Kevin A D'Amour, Allan J Robins
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37004 (2012)
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated tha
Externí odkaz:
https://doaj.org/article/217b85207ea64dde8656ee24573940b2
Autor:
Justine J Cunningham, Mike Richardson, Kuniko Kadoya, Nora G. Smart, Melissa K. Carpenter, Susan Eliazer, Holly Y. Young, Emmanuel E. Baetge, Anne G. Bang, Olivia Kelly, Evert Kroon, Alan D. Agulnick, Laura Martinson, Kevin A. D'Amour
Publikováno v:
Nature Biotechnology. 26:443-452
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human β-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c2264a079324d8e12ea8bed61c0ef3
https://doi.org/10.1038/nbt1393
https://doi.org/10.1038/nbt1393
Publikováno v:
Transplantation. 78:509-515
BACKGROUND Major histocompatibility complex (MHC) molecules are essential determinants of beta-cell destruction in type 1 diabetes (T1D). MHC class I- or class II-null nonobese diabetic (NOD) mice do not spontaneously develop autoimmune diabetes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbcfae1ae81dc5270252bfbc1360360a
https://doi.org/10.1097/01.tp.0000128907.83111.c6
https://doi.org/10.1097/01.tp.0000128907.83111.c6
Autor:
Melissa K. Carpenter, Ralph Brandenberger, Holly Y. Young, Takumi Miura, Yongquan Luo, Jane S. Lebkowski, Mahendra S. Rao, Tom Vasicek, Daixing Zhou, R. Scott Thies, Irina Khrebtukova
Publikováno v:
Stem cells and development. 13(6)
To identify genes that may be involved in the process of human embryonic stem cell (hESC) differentiation, we profiled gene expression by expressed sequenced tag (EST) enumeration and massively parallel signature sequencing (MPSS) using RNA samples f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe30c2e8545908ca1c5d846ff2c55f6
https://pubmed.ncbi.nlm.nih.gov/15684837
https://pubmed.ncbi.nlm.nih.gov/15684837
Autor:
Carl Haakmeester, Chad Green, Kuniko Kadoya, Mark A. Moorman, Janice K. Payne, Amanda B. McLean, Laura Martinson, Rosemary M. Cesario, Mike Richardson, Eric S. Sherrer, Evert Kroon, M. Josephine Babin, Justin Kerr, Igor Cepa, Alistair Wilson, Olivia Kelly, Allan J. Robins, Emmanuel E. Baetge, Kevin A. D'Amour, Eugene P. Brandon, Jonathan R. Kelly, Kelly G. Ross, Xuehong Song, Anindita Bhoumik, Anne G. Bang, Thomas C. Schulz, Alan D. Agulnick, Holly Y. Young
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37004 (2012)
PLoS ONE
PLoS ONE
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7298272eaeb15ef99cb7d619a692a472
https://doi.org/10.1371/journal.pone.0037004
https://doi.org/10.1371/journal.pone.0037004